Literature DB >> 15094109

The thrombospondins.

Josephine C Adams1, Jack Lawler.   

Abstract

Thrombospondin-1 (TSP-1) was studied in the 1980s as a major component of platelet alpha-granules released upon platelet activation and also as a cell adhesion molecule. In 1993, we published a short review that discussed the exciting identification by molecular cloning of four additional vertebrate gene products related to TSP-1 [Current Biology 3 (1993) 188]. We put forward a structurally based classification for the newly identified proteins and discussed the functional and evolutionary implications of the new gene family. Since that time, the depth and breadth of knowledge on vertebrate TSPs and their functions in cells and tissues in health and disease has expanded into important new areas. Of particular interest is the new knowledge on the complex, domain and cell-type specific effects of TSPs on cell-signaling and cell-adhesion behaviour, the roles of TSP-1 and TSP-2 as anti-angiogenic agents, the roles of TSP-1 and TSP-2 in wound-healing, and associations of point mutations and polymorphisms in TSP-1, TSP-4 and TSP-5/COMP with human genetic diseases. The TSP family also now includes invertebrate members. In this article, we give the 2004 view on TSPs and our perspectives on the significant challenges that remain. Other articles in this issue discuss the functions of vertebrate TSPs in depth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094109      PMCID: PMC2885884          DOI: 10.1016/j.biocel.2004.01.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  36 in total

1.  Extracellular matrix: the thrombospondin family.

Authors:  J Adams; J Lawler
Journal:  Curr Biol       Date:  1993-03       Impact factor: 10.834

2.  Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity.

Authors:  T R Kyriakides; K J Leach; A S Hoffman; B D Ratner; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction.

Authors:  S Matthijs Boekholdt; Mieke D Trip; Ron J G Peters; Marc Engelen; Jolanda M A Boer; Edith J M Feskens; Aeilko H Zwinderman; John J P Kastelein; Pieter H Reitsma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-12-01       Impact factor: 8.311

Review 4.  Thrombospondin 2, a matricellular protein with diverse functions.

Authors:  P Bornstein; L C Armstrong; K D Hankenson; T R Kyriakides; Z Yang
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

5.  Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.

Authors:  T Hawighorst; P Velasco; M Streit; Y K Hong; T R Kyriakides; L F Brown; P Bornstein; M Detmar
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

6.  Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs.

Authors:  Sally C Dickinson; Mireille N Vankemmelbeke; David J Buttle; Krisztina Rosenberg; Dick Heinegård; Anthony P Hollander
Journal:  Matrix Biol       Date:  2003-05       Impact factor: 11.583

7.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

8.  New evidence for genome-wide duplications at the origin of vertebrates using an amphioxus gene set and completed animal genomes.

Authors:  Georgia Panopoulou; Steffen Hennig; Detlef Groth; Antje Krause; Albert J Poustka; Ralf Herwig; Martin Vingron; Hans Lehrach
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

9.  SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

Authors:  A Mettouchi; F Cabon; N Montreau; P Vernier; G Mercier; D Blangy; H Tricoire; P Vigier; B Binétruy
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1.

Authors:  S Godyna; G Liau; I Popa; S Stefansson; W S Argraves
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  180 in total

1.  Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Authors:  Sten-Erik Bergström; Mehmet Uzunel; Toomas Talme; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

Review 2.  Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix.

Authors:  Arul Subramanian; Thomas F Schilling
Journal:  Development       Date:  2015-12-15       Impact factor: 6.868

3.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

4.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

5.  Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.

Authors:  Balveen Kaur; Sarah M Cork; Eric M Sandberg; Narra S Devi; Zhaobin Zhang; Philip A Klenotic; Maria Febbraio; Hyunsuk Shim; Hui Mao; Carol Tucker-Burden; Roy L Silverstein; Daniel J Brat; Jeffrey J Olson; Erwin G Van Meir
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

6.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

Review 7.  Invoking the power of thrombospondins: regulation of thrombospondins expression.

Authors:  Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-02-25       Impact factor: 11.583

Review 8.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

9.  Thrombospondin-4 and excitatory synaptogenesis promote spinal sensitization after painful mechanical joint injury.

Authors:  Nathan D Crosby; Frank Zaucke; Jeffrey V Kras; Ling Dong; Z David Luo; Beth A Winkelstein
Journal:  Exp Neurol       Date:  2014-12-05       Impact factor: 5.330

Review 10.  Role of unusual O-glycans in intercellular signaling.

Authors:  Kelvin B Luther; Robert S Haltiwanger
Journal:  Int J Biochem Cell Biol       Date:  2008-10-08       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.